Received Mar 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | Z006736 | IM / RL |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 3 | y005457 | IM / LL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | z014435 | IM / RL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 4 | mm0513 | IM / LL |
The MA who administered the vaccines erroneously mixed the MMRV with Beyfortus (RSV) and injected it, instead of mixing MMRV with sterile dilutant. The patient had no adverse outside the normal fussiness and mild fever for 1-2 days.
Pneumonia
none
none; Beyfortus
NKDA
Patient was reevaluated on 3/6/2026 by myself, Dr., and found to have no signs or symptoms of adverse reactions. Vitals WNL.